Related Experiment Video
Updated: Jun 15, 2026
09:07
Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
Published on: December 19, 2018
Estrogenic regulation of limbic cannabinoid receptor binding
Caitlin J N Riebe1, Matthew N Hill, Tiffany T Y Lee
1Department of Psychology, University of British Columbia, Vancouver, BC, Canada.
Psychoneuroendocrinology
|March 9, 2010
Summary
Estradiol influences cannabinoid receptor binding in brain regions affecting stress and emotion. Sex differences in receptor density were observed, particularly in the hypothalamus and amygdala.
Area of Science:
- Neuroscience
- Endocrinology
- Pharmacology
Background:
- Sex differences in cannabinoid effects are well-documented.
- Estrogen is implicated in these variations, but its impact on cannabinoid receptor binding in key brain areas is unclear.
Purpose of the Study:
- To investigate sex differences in cannabinoid receptor binding.
- To determine the role of estradiol in regulating cannabinoid receptor density in brain regions involved in stress and emotional behavior.
Main Methods:
- Compared cannabinoid receptor binding site density in the amygdala, hippocampus, and hypothalamus.
- Utilized male, cycling female, ovariectomized (OVX) female, and estradiol-treated OVX (OVX+E) female rodents.
Main Results:
- Males and OVX females showed higher hypothalamic and lower amygdalar cannabinoid receptor binding compared to cycling and OVX+E females.
- Ovariectomy led to increased cannabinoid receptor binding in the hippocampus.
Conclusions:
- Estradiol modulates cannabinoid receptor binding in a region-specific manner.
- These findings suggest a biochemical basis for sex differences in cannabinoid effects on stress and emotional behavior.
Related Concept Videos
01:31Transducer Mechanism: Nuclear Receptors
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
01:31Internal Receptors
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
01:15Functional Brain Systems: Limbic System
The limbic system, often called the "emotional brain," is a complex set of structures located deep within the brain. The intricate network of the limbic system supports a wide range of psychological functions, from emotional regulation to memory formation and sensory processing. This functional brain region encompasses specific parts of the diencephalon and the cerebrum, integrating the higher mental functions of the cerebral cortex with the primitive emotional responses of the deep brain...
01:29The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...
01:22Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
01:24Tissue-Drug Binding: Localization of Drugs and its Significance
Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine the...
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine the...